Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael F Duarte

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Stem Cells International|January 8, 2026
Safety, Feasibility, and Preliminary Efficacy of Allogeneic MSCs to Treat Advanced Femoral Head Osteonecrosis (ALOFEM): A Pilot Study in Young Onco-Hematological PatientsEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Juan Cabello-Blanco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2011
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomideFlorent Malard, Nicolaus Kröger, Ian H Gabriel, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Trials|January 7, 2021
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trialConcepción Payares-Herrera, María E Martínez-Muñoz, Inés Lipperheide Vallhonrat, et al.
Bone Marrow Transplantation|May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantationMohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based ApproachRafael Ríos-Tamayo, María José Sánchez, Sandra Gómez-Rojas, et al.
The Lancet. HIV|October 2, 2015
CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case reportRafael F Duarte, María Salgado, Isabel Sánchez-Ortega, et al.
Bone Marrow Transplantation|January 14, 2018
Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteriaHiromi Hayashi, Annalisa Ruggeri, Fernanda Volt, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Haematologica|June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trialHelene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Stem Cells International|January 8, 2026
Safety, Feasibility, and Preliminary Efficacy of Allogeneic MSCs to Treat Advanced Femoral Head Osteonecrosis (ALOFEM): A Pilot Study in Young Onco-Hematological PatientsEnrique Gómez-Barrena, Norma G Padilla-Eguiluz, Juan Cabello-Blanco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2011
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomideFlorent Malard, Nicolaus Kröger, Ian H Gabriel, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Trials|January 7, 2021
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trialConcepción Payares-Herrera, María E Martínez-Muñoz, Inés Lipperheide Vallhonrat, et al.
Bone Marrow Transplantation|May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantationMohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based ApproachRafael Ríos-Tamayo, María José Sánchez, Sandra Gómez-Rojas, et al.
The Lancet. HIV|October 2, 2015
CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case reportRafael F Duarte, María Salgado, Isabel Sánchez-Ortega, et al.
Bone Marrow Transplantation|January 14, 2018
Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteriaHiromi Hayashi, Annalisa Ruggeri, Fernanda Volt, et al.
The Lancet. Haematology|September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Haematologica|June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trialHelene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Pageof 12